Notably, a report indicated that vascular endothelial growth factor A (VEGFA) antagonized by angiotensin-converting enzyme 2 (ACE2) that is upregulated by COVID-19 infection because COVID-19 inhibits the expression of ACE2. The gene discussed is VEGFA; the disease is COVID-19.